O, M., W, D., V, G., K, M., S, S., M, B., . . . F, I. (2025). HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model. Nature communications, 16(1), 9090. https://doi.org/10.1038/s41467-025-64945-3
Chicago Style (17th ed.) CitationO, McCallion, et al. "HLA Matching or CRISPR Editing of HLA Class I/II Enables Engraftment and Effective Function of Allogeneic Human Regulatory T Cell Therapy in a Humanized Mouse Transplantation Model." Nature Communications 16, no. 1 (2025): 9090. https://doi.org/10.1038/s41467-025-64945-3.
MLA (9th ed.) CitationO, McCallion, et al. "HLA Matching or CRISPR Editing of HLA Class I/II Enables Engraftment and Effective Function of Allogeneic Human Regulatory T Cell Therapy in a Humanized Mouse Transplantation Model." Nature Communications, vol. 16, no. 1, 2025, p. 9090, https://doi.org/10.1038/s41467-025-64945-3.